284 related articles for article (PubMed ID: 20979796)
21. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
22. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD
Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742
[TBL] [Abstract][Full Text] [Related]
23. Trends in Mycobacterium tuberculosis resistance, Pakistan, 1990-2007.
Hasan R; Jabeen K; Mehraj V; Zafar F; Malik F; Hassan Q; Azam I; Kadir MM
Int J Infect Dis; 2009 Nov; 13(6):e377-82. PubMed ID: 19369103
[TBL] [Abstract][Full Text] [Related]
24. Characterization of extensively drug-resistant Mycobacterium tuberculosis in Nepal.
Poudel A; Maharjan B; Nakajima C; Fukushima Y; Pandey BD; Beneke A; Suzuki Y
Tuberculosis (Edinb); 2013 Jan; 93(1):84-8. PubMed ID: 23146281
[TBL] [Abstract][Full Text] [Related]
25. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of drug resistance in Mycobacterium tuberculosis.
Zhang Y; Yew WW
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
[TBL] [Abstract][Full Text] [Related]
27. gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis.
Sirgel FA; Warren RM; Streicher EM; Victor TC; van Helden PD; Böttger EC
J Antimicrob Chemother; 2012 May; 67(5):1088-93. PubMed ID: 22357804
[TBL] [Abstract][Full Text] [Related]
28. Detection of multidrug resistance in Mycobacterium tuberculosis.
Sekiguchi J; Miyoshi-Akiyama T; Augustynowicz-Kopeć E; Zwolska Z; Kirikae F; Toyota E; Kobayashi I; Morita K; Kudo K; Kato S; Kuratsuji T; Mori T; Kirikae T
J Clin Microbiol; 2007 Jan; 45(1):179-92. PubMed ID: 17108078
[TBL] [Abstract][Full Text] [Related]
29. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
Kurabachew M; Lu SH; Krastel P; Schmitt EK; Suresh BL; Goh A; Knox JE; Ma NL; Jiricek J; Beer D; Cynamon M; Petersen F; Dartois V; Keller T; Dick T; Sambandamurthy VK
J Antimicrob Chemother; 2008 Oct; 62(4):713-9. PubMed ID: 18587134
[TBL] [Abstract][Full Text] [Related]
30. Extensively drug-resistant tuberculosis: new strains, new challenges.
Banerjee R; Schecter GF; Flood J; Porco TC
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
[TBL] [Abstract][Full Text] [Related]
31. Mutations in the gyrA and gyrB genes of fluoroquinolone-resistant Mycobacterium tuberculosis from TB patients in Thailand.
Pitaksajjakul P; Wongwit W; Punprasit W; Eampokalap B; Peacock S; Ramasoota P
Southeast Asian J Trop Med Public Health; 2005; 36 Suppl 4():228-37. PubMed ID: 16438215
[TBL] [Abstract][Full Text] [Related]
32. Underestimation of the resistance of Mycobacterium tuberculosis to second-line drugs by the new GenoType MTBDRsl test.
Jin J; Shen Y; Fan X; Diao N; Wang F; Wang S; Weng X; Zhang W
J Mol Diagn; 2013 Jan; 15(1):44-50. PubMed ID: 23159109
[TBL] [Abstract][Full Text] [Related]
33. Extensively drug-resistant tuberculosis: current challenges and threats.
Jain A; Mondal R
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
[TBL] [Abstract][Full Text] [Related]
34. [Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing].
Chen X; Ma Y; Jin Q; Jiang GL; Li CY; Wang Q
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):250-3. PubMed ID: 15854436
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of efflux pump genes in extensively drug-resistant isolates of Mycobacterium tuberculosis.
Kanji A; Hasan R; Zhang Y; Shi W; Imtiaz K; Iqbal K; Shafiq S; Hasan Z
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S150. PubMed ID: 28043519
[TBL] [Abstract][Full Text] [Related]
36. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
Gill SK; Garcia GA
Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
[TBL] [Abstract][Full Text] [Related]
37. Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis.
Naidoo CC; Pillay M
Clin Microbiol Infect; 2014 Jun; 20(6):O361-9. PubMed ID: 24118525
[TBL] [Abstract][Full Text] [Related]
38. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid.
Escribano I; Rodríguez JC; Llorca B; García-Pachon E; Ruiz M; Royo G
Chemotherapy; 2007; 53(6):397-401. PubMed ID: 17934259
[TBL] [Abstract][Full Text] [Related]
39. Strain differentiation of Mycobacterium tuberculosis complex isolated from sputum of pulmonary tuberculosis patients.
Abbadi S; El Hadidy G; Gomaa N; Cooksey R
Int J Infect Dis; 2009 Mar; 13(2):236-42. PubMed ID: 18838283
[TBL] [Abstract][Full Text] [Related]
40. Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections.
Amaral L; Viveiros M
Int J Antimicrob Agents; 2012 May; 39(5):376-80. PubMed ID: 22445204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]